Myriad Genetics Q2 2017 Earnings

Myriad Genetics reported fiscal Q2 2017 earnings results, beating guidance on both revenue and earnings per share. The company disclosed financial performance including GAAP and non-GAAP measures, with revenue of $196.5 million and adjusted EPS of $0.26, alongside discussion of acquisition-related charges from the Assurex acquisition.